Institution
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
- 3running trials
- 3,879publications (OpenAlex)
Running trials
Recruiting
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Recruiting
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Active, not recruiting
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Liver and biliary tract cancer1 recruiting
Registry name variants (1)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston, Massachusetts 02215
3 trials
NCT04634357ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Contact: Jill MacDonald
NCT04943848rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Contact: Alexa E Stathis
NCT03301168Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Conditions
Diseases this institution publishes on or runs trials for.
- Childhood cancers46 works · 3 trials
- Sarcoma28 works · 0 trials
- Neuroblastoma27 works · 0 trials
- Sickle cell disease15 works · 0 trials
- Immune thrombocytopenia (ITP)13 works · 0 trials
- Aplastic anaemia4 works · 1 trial
Institution data: ROR 05k11pb55 (CC0-1.0)Updated 15 Nov 2026